Cl.C(O[C:7]([N:9]1[CH2:30][CH2:29][CH2:28][C@H:10]1[C:11]([N:13]1[CH2:17][CH2:16][CH2:15][C@H:14]1[CH:18]([OH:27])[CH2:19][O:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1)=[O:12])=[O:8])(C)(C)C.Cl.[C:32]1([CH2:38][C@H:39]([N:43]2[CH2:48][CH2:47][CH2:46][CH2:45][CH2:44]2)C(O)=O)[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1>>[OH:27][CH:18]([C@@H:14]1[CH2:15][CH2:16][CH2:17][N:13]1[C:11](=[O:12])[C@@H:10]1[CH2:28][CH2:29][CH2:30][N:9]1[C:7](=[O:8])[C@@H:39]([N:43]1[CH2:48][CH2:47][CH2:46][CH2:45][CH2:44]1)[CH2:38][C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1)[CH2:19][O:20][C:21]1[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=1The residue obtained by treating, with 4N hydrochloric acid, (2S)-1-[N-(tert-butoxycarbonyl)-L-prolyl]-2-(1-hydroxy-2-phenoxyethyl)pyrrolidine (751 mg) prepared in Example 46-C) was subjected to condensation with (2S)-3-phenyl-2-(1-piperidinyl)propionic acid hydrochloride (500 mg) in the same manner as in Example 48-B) to give 818 mg of the title compound.
불러오는 중…